Stress Response Modulation Underlying the Psychobiology of Resilience
Purpose of Review
This review focuses on the relationship between resilience and the ability to effectively modulate the stress response. Neurobiological and behavioral responses to stress are highly variable. Exposure to a similar stressor can lead to heterogeneous outcomes—manifesting psychopathology in one individual, but having minimal effect, or even enhancing resilience, in another. We highlight aspects of stress response modulation related to early life development and epigenetics, selected neurobiological and neurochemical systems, and a number of emotional, cognitive, psychosocial, and behavioral factors important in resilience. We also briefly discuss interventions with potential to build and promote resilience.
Throughout this review, we include evidence from recent preclinical and clinical studies relevant to the psychobiology of resilient stress response modulation.
Effective modulation of the stress response is an essential component of resilience and is dependent on a complex interplay of neurobiological and behavioral factors.
KeywordsResilience Stress Trauma Neurobiology Intervention
The authors acknowledge the support from the US Department of Veterans Affairs through its support for the National Center for PTSD. We also recognize the National Center for Advancing Translational Science for its support of the Yale Center for Clinical Investigation (UL1RR024139). In addition, the authors acknowledge the support from the US Department of Veterans Affairs VISN 1 Research Office (Career Development Award, LAA), Brain and Behavior Research Foundation (LAA, CGA, BK), and the Robert E. Leet and Clara Guthrie Patterson Mentored Clinical Research Trust (LAA).
Compliance with Ethical Standards
Conflict of Interest
Lynnette A. Averill, Christopher L. Averill, Benjamin Kelmendi, and Steven M. Southwick declare no conflict of interest.
Chadi G. Abdallah has received personal fees from Janssen and Genentech, both outside the submitted work.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 3.Southwick, S.M., Pietrzak, R.H., Tsai, J., Krystal, J.H., Resilience: an update PTSD Research Quarterly 2015. 25(4).Google Scholar
- 4.Horn, S.R., D.S. Charney, and A. Feder, Understanding resilience: new approaches for preventing and treating PTSD. Exp Neurol, 2016. 284(Pt B): p. 119–132.Google Scholar
- 5.• McEwen BS. In pursuit of resilience: stress, epigenetics, and brain plasticity. Ann N Y Acad Sci. 2016;1373(1):56–64. https://doi.org/10.1111/nyas.13020. A current, comprehensive, and thoughtful review of the role of stress, genetics, and neuroplasticity in resilience. PubMedCrossRefGoogle Scholar
- 12.• Masten AS. Global perspectives on resilience in children and youth. Child Dev. 2014;85(1):6–20. https://doi.org/10.1111/cdev.12205. A current and important review highlighting the global importance of building resilience and the interaction between development and resilience. This also highlights many factors ranging from global, regional, community, to cultural levels that influence resilience. PubMedCrossRefGoogle Scholar
- 23.•• Yehuda R, Daskalakis NP, Bierer LM, Bader HN, Klengel T, Holsboer F, et al. Holocaust exposure induced intergenerational effects on FKBP5 methylation. Biol Psychiatry. 2016;80(5):372–80. https://doi.org/10.1016/j.biopsych.2015.08.005. The first study to demonstrate the effects of intergenerational trauma on the FKBP5 myelination. PubMedCrossRefGoogle Scholar
- 31.• Arnsten AF, Raskind MA, Taylor FB, Connor DF. The effects of stress exposure on prefrontal cortex: translating basic research into successful treatments for post-traumatic stress disorder. Neurobiol Stress. 2015;1:89–99. https://doi.org/10.1016/j.ynstr.2014.10.002. A comprehensive review of the deleterious effects of stress on the PFC including discussion of pharmacologic interventions to ameloriate or reverse these effects. PubMedCrossRefGoogle Scholar
- 36.• Schmeltzer SN, Herman JP, Sah R. Neuropeptide Y (NPY) and posttraumatic stress disorder (PTSD): a translational update. Experimental neurology. 2016;284(Pt B):196-210. Doi: https://doi.org/10.1016/j.expneurol.2016.06.020. A current review providing evidence from clinical to preclinical data regarding the role of NPY in PTSD and resilience.
- 45.• Galatzer-Levy IR, Ma S, Statnikov A, Yehuda R, Shalev AY. Utilization of machine learning for prediction of post-traumatic stress: a re-examination of cortisol in the prediction and pathways to non-remitting PTSD. Translational psychiatry. 2017;7(3):e0. doi: https://doi.org/10.1038/tp.2017.38. A review of novel, advanced computational methods to better inform neurobiological studies, in this case, the role of cortisol in PTSD.
- 47.Galatzer-Levy IR, Steenkamp MM, Brown AD, Qian M, Inslicht S, Henn-Haase C, et al. Cortisol response to an experimental stress paradigm prospectively predicts long-term distress and resilience trajectories in response to active police service. J Psychiatr Res. 2014;56:36–42.PubMedPubMedCentralCrossRefGoogle Scholar
- 55.Charney, D.S. and H.K. Manji, Life stress, genes, and depression: multiple pathways lead to increased risk and new opportunities for intervention. Sci STKE, 2004. 2004(225): p. re5.Google Scholar
- 60.• Watkins LE, Han S, Harpaz-Rotem I, Mota NP, Southwick SM, Krystal JH, et al. FKBP5 polymorphisms, childhood abuse, and PTSD symptoms: results from the National Health and Resilience in Veterans Study. Psychoneuroendocrinology. 2016;69:98–105. https://doi.org/10.1016/j.psyneuen.2016.04.001. This reports on the interaction between FKBP5 and childhood abuse in the later onset of PTSD among a nationally representative sample of Veterans. PubMedCrossRefGoogle Scholar
- 62.Coric V, Feldman HH, Oren DA, Shekhar A, Pultz J, Dockens RC, et al. Multicenter, randomized, double-blind, active comparator and placebo-controlled trial of a corticotropin-releasing factor receptor-1 antagonist in generalized anxiety disorder. Depress Anxiety. 2010;27(5):417–25.PubMedCrossRefGoogle Scholar
- 66.•• Johnson EC, Border R, Melroy-Greif WE, de Leeuw CA, Ehringer MA, Keller MC. No evidence that schizophrenia candidate genes are more associated with schizophrenia than noncandidate genes. Biol Psychiatry. 2017;82:702–8. https://doi.org/10.1016/j.biopsych.2017.06.033. This study evaluted the larged schizophrenia GWAS to date and found that many of the previously identified canidate genes are not well supported in genome-wide studies. These results highlight the caution that must be taken in interpreting results from canidate gene studies. PubMedCrossRefGoogle Scholar
- 70.• Park CH, Kim J, Namgung E, Lee DW, Kim GH, Kim M, et al. The BDNF Val66Met polymorphism affects the vulnerability of the brain structural network. Front Hum Neurosci. 2017;11:400. https://doi.org/10.3389/fnhum.2017.00400. This study reports on the role of BDNF Val66Met polymorphism in neuroplasticity and white matter stucture that may influence risk of psychopathology. PubMedPubMedCentralCrossRefGoogle Scholar
- 76.Gatt JM, Nemeroff CB, Schofield PR, Paul RH, Clark CR, Gordon E, et al. Early life stress combined with serotonin 3A receptor and brain-derived neurotrophic factor valine 66 to methionine genotypes impacts emotional brain and arousal correlates of risk for depression. Biol Psychiatry. 2010;68(9):818–24.PubMedCrossRefGoogle Scholar
- 77.• Averill LA, Purohit P, Averill CL, Boesl MA, Krystal JH, Abdallah CG. Glutamate dysregulation and glutamatergic therapeutics for PTSD: evidence from human studies. Neurosci Lett. 2017;649:147–55. https://doi.org/10.1016/j.neulet.2016.11.064. This review is among the first to consolidate and present the clinical evidence of glutamatergic dysregulation and related potential therapeutic targets in PTSD. PubMedCrossRefGoogle Scholar
- 80.Faye, C., et al., Neurobiological mechanisms of stress resilience and implications for the aged population. Curr Neuropharmacol, 2017.Google Scholar
- 81.• Kelmendi B, Adams TG, Yarnell S, Southwick S, Abdallah CG, Krystal JH: PTSD from neurobiology to pharmacological treatments. Eur J Psychotraumatol 2016;7:31858. doi:10.3402/ejpt.v7.31858. A current review concisely describing both FDA-approved and investigational therapeutic options for PTSD and their related underlying neurobiological mechanisms. Google Scholar
- 83.• Murrough JW, Abdallah CG, Mathew SJ. Targeting glutamate signalling in depression: progress and prospects. Nat Rev Drug Discov. 2017;16(7):472–86. https://doi.org/10.1038/nrd.2017.16. A current review of the progress and current status in identifying novel glutamatergic-based treatment targets for antidepressant-resistant depression. PubMedCrossRefGoogle Scholar
- 84.• Krystal JH, Abdallah CG, Averill LA, Kelmendi B, Harpaz-Rotem I, Sanacora G, et al. Synaptic loss and the pathophysiology of PTSD: implications for ketamine as a prototype novel therapeutic. Current psychiatry reports. 2017;19(10):74. https://doi.org/10.1007/s11920-017-0829-z. A current review highlighting the novel antidepressant ketamine’s positive effects on synaptic health in PTSD. PubMedCrossRefPubMedCentralGoogle Scholar
- 88.• Lee TT, Hill MN, Lee FS. Developmental regulation of fear learning and anxiety behavior by endocannabinoids. Genes Brain Behav. 2016;15(1):108–24. https://doi.org/10.1111/gbb.12253. A current review discussing the role of endocannabinoids in fear response and anxious behavior through evidence from human and rodent studies. PubMedCrossRefGoogle Scholar
- 90.• Akiki, T.J., C.L. Averill, and C.G. Abdallah, A network-based neurobiological model of PTSD: evidence from structural and functional neuroimaging studies. Curr Psychiatry Rep, 2017. 19(11): p. 81. This timely review highlights findings of large-scale structural and functional network dysruptions in PTSD and proposes a novel network-based model of PTSD. Google Scholar
- 95.• LeDoux JE. Coming to terms with fear. Proc Natl Acad Sci U S A. 2014;111(8):2871–8. https://doi.org/10.1073/pnas.1400335111. A current and comprehensive review of the neurobiological underpinnings of fear response and a discussion of recently proposed survival circuits and global organismic states. PubMedPubMedCentralCrossRefGoogle Scholar
- 98.Troy, A.S. and I.B. Mauss, Resilience in the face of stress: emotion regulation as a protective factor. , in Resilience and mental health: challenges across the lifespan, S.M. Southwick, Litz, B.T., Charney, D., & Friedman, M.J. , Editor. 2011, Cambridge University Press.Google Scholar
- 99.Gross JJ, Thompson RA. Emotion regulation: conceptual foundations. In: Gross JJ, editor. Handbook of Emotion Regulation. New York: Guilford Press; 2007. p. 3–24.Google Scholar
- 101.• Dore BP, Boccagno C, Burr D, Hubbard A, Long K, Weber J, et al. Finding positive meaning in negative experiences engages ventral striatal and ventromedial prefrontal regions associated with reward valuation. J Cogn Neurosci. 2017;29(2):235–44. https://doi.org/10.1162/jocn_a_01041. An MRI study highlighting the role of the ventral striatum and PFC in positive cognitive reappraisal and the relationship between reappraisal and reward circuitry. PubMedCrossRefGoogle Scholar
- 103.• Reeck C, Ames DR, Ochsner KN. The social regulation of emotion: an integrative, cross-disciplinary model. Trends Cogn Sci. 2016;20(1):47–63. https://doi.org/10.1016/j.tics.2015.09.003. This provides a unique perspective on the social aspects underlying much of emotion regulation. PubMedCrossRefGoogle Scholar
- 105.• Kuzmanovic B, Jefferson A, Vogeley K. The role of the neural reward circuitry in self-referential optimistic belief updates. NeuroImage. 2016;133:151–62. https://doi.org/10.1016/j.neuroimage.2016.02.014. An MRI study highlighting the role of the PFC and ventral striatum in optimistic judgements. PubMedCrossRefGoogle Scholar
- 129.Moyal N, Henik A, Anholt GE. Cognitive strategies to regulate emotions—current evidence and future directions. Front Psychol. 2013;4:1019.Google Scholar
- 130.•• Bagot RC, et al. Ketamine and imipramine reverse transcriptional signatures of susceptibility and induce resilience-specific gene expression profiles. Biological Psychiatry. 2017;81(4):285–95. This paper investigates the ability of ketamine (and imipramine) to alter transcriptional mechanisms of vulnerability and resilience to stress, which has significant impliations for these drugs as novel treatment targets in stress-related psychopathology. Specifically, they found both drugs were able to reverse transcriptionally-based vulnerabilities and enhance resilience. PubMedCrossRefGoogle Scholar
- 133.•• Brachman RA, et al. Ketamine as a prophylactic against stress-induced depressive-like behavior. Biol Psychiatry. 2016;79(9):776–86. This paper provides pre-clinical evidence that ketamine can induce resilience to stress and may be a useful preventative measure protecting against stress-related psychopathology. PubMedCrossRefGoogle Scholar
- 135.• Lutz B, et al. The endocannabinoid system in guarding against fear, anxiety and stress. Nature Reviews Neuroscience. 2015;16:705. This review provides a nice summary of the role of endocannabinoid system signaling and modulation in stress response, including fear reactions and stress coping. PubMedPubMedCentralCrossRefGoogle Scholar
- 142.Andersen, J., et al., Highly realistic scenario based training simulates the psychophysiology of real world use of force encounters: implications for improved police officer performance. Vol. 5. 2016. 1–13.Google Scholar